Nifty
:
23907.25
Sensex
:
79117.11
557.35 (2.39%)
1961.32 (2.54%)
Nifty
Sensex
:
:
23907.25
79117.11
557.35 (2.39%)
1961.32 (2.54%)

Granules India Ltd.

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 532482 | NSE: GRANULES

NSE BSE
526.00
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  518.95
  •  530.65
  •  511.55
  •  514.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3974182
  •  20801.67
  •  721.00
  •  365.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 13,545.99
  • 27.41
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 14,338.67
  • 0.27%
  • 3.90

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 38.87%
  • 4.36%
  • 18.29%
  • FII
  • DII
  • Others
  • 19.49%
  • 13.98%
  • 5.01%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.30
  • 11.64
  • 6.18

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.16
  • 10.26
  • 3.47

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.12
  • 5.51
  • -0.61

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.96
  • 16.94
  • 18.09

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.97
  • 3.33
  • 3.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.93
  • 11.32
  • 11.54

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
966.62
1,189.49
-18.74%
1,179.87
985.52
19.72%
1,175.78
1,195.50
-1.65%
1,155.58
1,146.13
0.82%
Expenses
763.30
976.51
-21.83%
920.60
848.69
8.47%
920.08
967.38
-4.89%
905.10
914.83
-1.06%
EBITDA
203.32
212.97
-4.53%
259.27
136.82
89.50%
255.70
228.12
12.09%
250.48
231.29
8.30%
EBIDTM
21.03%
17.90%
21.97%
13.88%
21.75%
19.08%
21.68%
20.18%
Other Income
3.25
1.53
112.42%
2.06
0.35
488.57%
1.87
3.38
-44.67%
0.65
0.95
-31.58%
Interest
25.67
25.96
-1.12%
27.02
22.46
20.30%
28.76
18.80
52.98%
28.65
16.97
68.83%
Depreciation
52.52
52.52
0.00%
52.87
49.24
7.37%
53.18
48.71
9.18%
52.39
48.36
8.33%
PBT
128.38
136.02
-5.62%
181.44
65.47
177.13%
175.64
163.99
7.10%
170.09
166.90
1.91%
Tax
31.15
33.91
-8.14%
46.79
17.58
166.15%
45.99
44.38
3.63%
44.44
42.57
4.39%
PAT
97.23
102.12
-4.79%
134.65
47.89
181.17%
129.65
119.60
8.40%
125.65
124.33
1.06%
PATM
10.06%
8.58%
11.41%
4.86%
11.03%
10.00%
10.87%
10.85%
EPS
4.01
4.21
-4.75%
5.56
1.98
180.81%
5.35
4.94
8.30%
5.18
5.14
0.78%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
4,477.85
4,506.37
4,511.92
3,764.92
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
1,357.18
1,292.92
Net Sales Growth
-0.86%
-0.12%
19.84%
16.29%
24.59%
14.02%
35.29%
19.43%
3.93%
4.97%
 
Cost Of Goods Sold
1,818.59
2,021.25
2,307.28
1,883.64
1,391.28
1,280.93
1,255.56
896.32
679.63
725.03
746.95
Gross Profit
2,659.26
2,485.12
2,204.63
1,881.28
1,846.27
1,317.72
1,023.64
788.30
730.93
632.15
545.97
GP Margin
59.39%
55.15%
48.86%
49.97%
57.03%
50.71%
44.91%
46.79%
51.82%
46.58%
42.23%
Total Expenditure
3,509.08
3,650.39
3,598.60
3,043.30
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
1,081.29
1,084.31
Power & Fuel Cost
-
100.64
95.69
74.66
68.85
59.74
57.67
48.22
38.67
34.97
45.73
% Of Sales
-
2.23%
2.12%
1.98%
2.13%
2.30%
2.53%
2.86%
2.74%
2.58%
3.54%
Employee Cost
-
550.24
420.35
366.44
324.29
259.04
209.82
165.21
140.19
117.57
106.96
% Of Sales
-
12.21%
9.32%
9.73%
10.02%
9.97%
9.21%
9.81%
9.94%
8.66%
8.27%
Manufacturing Exp.
-
408.01
273.93
298.74
228.39
177.94
157.62
120.84
88.60
66.97
50.89
% Of Sales
-
9.05%
6.07%
7.93%
7.05%
6.85%
6.92%
7.17%
6.28%
4.93%
3.94%
General & Admin Exp.
-
211.99
187.96
134.41
172.28
125.63
99.96
83.05
67.65
60.38
59.84
% Of Sales
-
4.70%
4.17%
3.57%
5.32%
4.83%
4.39%
4.93%
4.80%
4.45%
4.63%
Selling & Distn. Exp.
-
290.63
280.00
247.45
159.80
112.17
91.84
83.08
81.37
67.75
71.70
% Of Sales
-
6.45%
6.21%
6.57%
4.94%
4.32%
4.03%
4.93%
5.77%
4.99%
5.55%
Miscellaneous Exp.
-
67.62
33.38
37.96
37.42
57.88
22.69
9.49
15.61
8.62
71.70
% Of Sales
-
1.50%
0.74%
1.01%
1.16%
2.23%
1.00%
0.56%
1.11%
0.64%
0.17%
EBITDA
968.77
855.98
913.32
721.62
855.23
525.32
384.04
278.42
298.84
275.89
208.61
EBITDA Margin
21.63%
18.99%
20.24%
19.17%
26.42%
20.22%
16.85%
16.53%
21.19%
20.33%
16.13%
Other Income
7.83
4.40
14.29
18.22
26.88
36.56
26.68
10.84
9.93
5.62
4.34
Interest
110.10
105.82
55.93
23.21
26.28
27.02
28.46
33.06
32.26
37.07
32.35
Depreciation
210.96
207.33
184.49
158.63
151.46
136.95
105.48
76.20
71.51
58.40
52.65
PBT
655.55
547.23
687.17
558.00
704.36
397.90
276.78
180.00
204.99
186.03
127.96
Tax
168.37
141.92
170.58
145.24
154.91
115.73
89.11
63.40
65.20
61.15
37.05
Tax Rate
25.68%
25.93%
24.82%
26.03%
21.99%
27.19%
32.20%
35.22%
31.81%
32.87%
28.95%
PAT
487.18
405.31
516.60
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
PAT before Minority Interest
487.18
405.31
516.60
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
10.88%
8.99%
11.45%
10.96%
16.97%
11.93%
8.23%
6.92%
9.91%
9.20%
7.03%
PAT Growth
23.67%
-21.54%
25.16%
-24.88%
77.30%
65.14%
60.95%
-16.59%
11.93%
37.38%
 
EPS
20.10
16.72
21.31
17.03
22.67
12.79
7.74
4.81
5.77
5.15
3.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
3,225.54
2,834.91
2,586.54
2,173.27
1,843.72
1,529.47
1,304.18
903.60
661.60
431.16
Share Capital
24.24
24.20
24.80
24.77
25.42
25.42
25.38
22.87
21.67
20.43
Total Reserves
3,183.00
2,792.68
2,545.01
2,126.23
1,800.02
1,493.09
1,273.38
878.28
611.13
410.74
Non-Current Liabilities
176.04
254.73
282.83
366.30
485.98
552.63
488.19
187.99
246.62
356.52
Secured Loans
68.97
148.64
233.70
333.81
414.83
478.78
433.13
123.90
183.66
302.59
Unsecured Loans
0.00
0.00
0.00
0.00
6.69
0.00
0.00
0.34
0.55
0.62
Long Term Provisions
37.88
29.26
28.31
24.84
21.50
12.58
7.70
7.25
5.58
4.03
Current Liabilities
2,082.29
1,813.50
1,641.60
1,173.10
893.40
896.48
877.91
787.13
654.75
415.03
Trade Payables
749.53
782.13
638.61
541.05
356.88
323.48
274.35
215.98
181.10
187.63
Other Current Liabilities
261.08
193.19
200.85
194.25
153.16
113.60
69.84
93.43
79.21
88.98
Short Term Borrowings
1,054.24
810.88
765.58
409.27
371.69
454.21
525.10
473.83
392.85
124.97
Short Term Provisions
17.45
27.31
36.56
28.53
11.66
5.20
8.62
3.90
1.58
13.45
Total Liabilities
5,483.87
4,903.14
4,511.53
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
1,562.97
1,202.71
Net Block
2,095.62
1,910.92
1,541.17
1,332.00
1,203.97
944.25
776.73
644.34
559.94
616.55
Gross Block
3,351.81
2,981.22
2,461.77
2,145.15
1,875.23
1,472.94
1,199.63
983.66
822.98
843.76
Accumulated Depreciation
1,256.19
1,070.30
920.59
813.15
671.26
528.69
422.90
339.32
263.05
227.21
Non Current Assets
2,578.83
2,328.99
2,006.54
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
744.97
699.69
Capital Work in Progress
271.70
239.39
356.23
239.08
294.20
495.95
514.52
267.43
76.56
62.03
Non Current Investment
21.52
21.21
19.67
18.99
19.34
210.42
156.56
108.23
70.11
0.19
Long Term Loans & Adv.
190.00
157.47
89.47
125.61
76.89
45.72
35.91
30.56
38.37
20.76
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.15
Current Assets
2,905.05
2,574.15
2,504.99
1,997.00
1,628.70
1,282.24
1,186.57
828.16
818.00
500.36
Current Investments
0.00
0.00
0.00
0.00
109.85
0.00
0.00
0.00
0.00
0.00
Inventories
1,300.55
1,149.41
978.55
782.18
438.43
384.21
279.95
269.18
253.72
224.52
Sundry Debtors
985.83
948.54
924.95
765.42
662.04
673.54
628.25
417.70
375.35
136.91
Cash & Bank
386.38
312.79
409.46
271.04
283.94
89.04
115.64
49.80
130.29
65.31
Other Current Assets
232.28
49.22
61.67
50.74
134.43
135.45
162.73
91.49
58.65
73.63
Short Term Loans & Adv.
186.00
114.19
130.35
127.61
91.83
98.46
114.09
51.66
48.68
2.05
Net Current Assets
822.75
760.65
863.38
823.90
735.30
385.76
308.65
41.03
163.25
85.33
Total Assets
5,483.88
4,903.14
4,511.53
3,712.68
3,223.11
2,978.58
2,670.28
1,878.71
1,562.97
1,202.72

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
439.41
738.75
332.06
432.48
476.19
262.24
-0.65
188.24
151.43
150.28
PBT
547.23
687.17
558.00
704.36
425.64
276.78
180.00
204.99
186.03
127.96
Adjustment
328.80
237.69
176.29
194.43
156.88
149.85
107.45
95.14
92.63
85.37
Changes in Working Capital
-246.32
-10.31
-257.19
-274.95
12.75
-75.94
-230.03
-52.37
-79.70
-31.34
Cash after chg. in Working capital
629.71
914.55
477.11
623.84
595.27
350.69
57.42
247.77
198.97
182.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-190.30
-175.80
-145.05
-191.37
-119.08
-88.45
-58.07
-59.53
-47.54
-31.72
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-360.16
-191.36
-380.12
-277.13
-160.63
-269.82
-462.31
-326.09
-161.65
-145.55
Net Fixed Assets
-101.04
-104.53
-302.61
-204.42
-124.57
-176.36
-282.01
-249.86
-75.62
-231.53
Net Investments
-264.87
-80.00
-5.00
-36.29
-48.78
-431.34
-0.01
13.84
-16.48
72.98
Others
5.75
-6.83
-72.51
-36.42
12.72
337.88
-180.29
-90.07
-69.55
13.00
Cash from Financing Activity
7.66
-440.29
190.00
-299.31
-212.85
-17.43
528.62
55.87
85.67
18.83
Net Cash Inflow / Outflow
86.92
107.10
141.94
-143.97
102.70
-25.01
65.66
-81.98
75.44
23.56
Opening Cash & Equivalents
291.56
184.71
41.84
185.93
83.02
108.03
42.37
124.35
54.85
41.75
Closing Cash & Equivalent
381.10
291.56
184.71
41.84
185.93
83.02
108.03
42.37
130.29
65.31

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
132.33
116.38
103.62
86.85
71.80
59.73
51.17
39.40
29.20
20.98
ROA
7.80%
10.97%
10.04%
15.84%
9.99%
6.64%
5.13%
8.12%
9.03%
8.31%
ROE
13.46%
19.18%
17.49%
27.64%
18.54%
13.32%
10.60%
18.23%
23.53%
23.29%
ROCE
15.66%
19.63%
17.37%
25.42%
17.22%
12.71%
11.09%
16.57%
20.16%
18.75%
Fixed Asset Turnover
1.42
1.66
1.63
1.97
1.75
1.78
1.55
1.59
1.66
1.77
Receivable days
78.34
75.78
81.94
65.94
83.34
100.03
112.83
100.84
67.60
33.47
Inventory Days
99.22
86.07
85.35
56.39
51.34
51.03
59.23
66.49
63.11
54.79
Payable days
138.29
112.38
114.29
117.79
58.20
54.96
62.37
64.87
59.99
53.57
Cash Conversion Cycle
39.26
49.48
52.99
4.54
76.48
96.10
109.70
102.46
70.72
34.69
Total Debt/Equity
0.38
0.38
0.43
0.39
0.49
0.65
0.75
0.73
1.01
1.14
Interest Cover
6.17
13.29
25.04
27.80
16.75
10.72
6.44
7.36
6.02
4.96

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Granules India receives Golden Peacock Award for sustainability
    14th Nov 2024, 16:55 PM

    This recognition follows a highly competitive selection process with 499 applicants and a rigorous three-tier assessment

    Read More
  • Granules India secures ANDA approval for Bupropion Hydrochloride Extended-Release Tablets
    18th Oct 2024, 14:59 PM

    Granules now has a total of 67 ANDA approvals from the USFDA

    Read More
  • Granules India unveils mobile cancer screening unit at AIG Hospitals
    24th Sep 2024, 14:39 PM

    The state-of-the-art mobile unit ‘Breast Health Express,’ brings advanced medical technology directly to communities in need

    Read More
  • USFDA completes inspection at Granules India’s Hyderabad facility
    9th Sep 2024, 10:23 AM

    The inspection, conducted from August 26, 2024 to September 06, 2024, concluded with six observations

    Read More
  • Granules India gets USFDA’s approval for Glycopyrrolate Oral Solution
    20th Aug 2024, 15:27 PM

    Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients aged three to 16 years who have neurological conditions associated with problem drooling

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.